Appropriators Agree On Boosting FDA's Supplement Sector Work, Not On Funding
This article was originally published in The Rose Sheet
Executive Summary
House and Senate appropriation bills state markedly different funding levels for FDA's spending on research into supplement and food products by its Center for Food Safety and Applied Nutrition and on enforcement work in the field by the Office of Regulatory Affairs. Appropriators are more aligned, though, in requests to FDA about its oversight of dietary supplement manufacturing and marketing.
You may also be interested in...
Toxicity Testing For Topical Drugs, Sunscreens Included, On Tap In US FDA Workshop
While FDA does not identify specific product types on the agenda for its public workshop on approaches in skin toxicity testing for topical drug products, advocacy and trade groups anticipate sunscreen ingredient testing could be among the discussion topics. Product expansions have been stifled by regulatory concerns, drawing particular attention from the public health community.
FDA Could Stick With Current Advice On NDI Notifications, Old Ingredient Evidence
FDA has little priority, and limited resources available for finalizing its 2016 draft guidance on NDI notifications and for establishing a process that certifies dietary ingredients as being available before October 1994, says regulatory attorney Miriam Guggenheim.For both of those developments, she says, "I'm not holding my breath."
Spray Sunscreens Stay In FDA Enforcement Discretion Shade
CDER's enforcement policy guidance for OTC monograph sunscreens clarifies that spray sunscreens are included in the agency's enforcement discretion. But CDER closes the door on other dosage forms that it also identified in its 2011 ANPR for whether delivery formats other than lotions, creams or other traditional forms would be eligible for the monograph.